Search research articles
Contact Us
Filters
Showing results (31-40 of 100) with videos related to
Page
of 10
Sort By:
European Journal of Internal Medicine
|
September 19, 2003
ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease
A Rutgers, P Heeringa, J G. Damoiseaux, et al.
British Journal of Rheumatology
|
September 12, 1998
Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis
A C Muller Kobold, C G Kallenberg, J W Tervaert
Annals of the Rheumatic Diseases
|
June 12, 1999
Monocyte activation in patients with Wegener's granulomatosis
A C Muller Kobold, C G Kallenberg, J W Tervaert
Kidney International
|
July 1, 1994
Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential
C G Kallenberg, E Brouwer, J J Weening, et al.
Current Opinion in Rheumatology
|
January 27, 2000
Is Wegener's granulomatosis an autoimmune disease?
P Hewins, J W Tervaert, C O Savage, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 8, 1987
[Analysis of symptoms preceding the diagnosis of Wegener's disease]
J W Tervaert, F J van der Woude, C G Kallenberg
Lancet (London, England)
|
January 13, 1996
c-ANCA as a marker of Wegener's disease
C F Franssen, J W Tervaert, C A Stegeman, et al.
Clinical and Experimental Immunology
|
March 1, 1993
Serum markers of T cell activation in relapses of Wegener's granulomatosis
C A Stegeman, J W Tervaert, M G Huitema, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Serum markers of T-cell activation in relapses of Wegener's granulomatosis
C A Stegeman, J W Tervaert, M G Huitema, et al.
Arthritis and Rheumatism
|
April 1, 1994
Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et al
J W Tervaert, C A Stegeman, M G Huitema, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 100) with videos related to
Sort By:
Page
of 10
European Journal of Internal Medicine
|
September 19, 2003
ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease
A Rutgers, P Heeringa, J G. Damoiseaux, et al.
British Journal of Rheumatology
|
September 12, 1998
Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis
A C Muller Kobold, C G Kallenberg, J W Tervaert
Annals of the Rheumatic Diseases
|
June 12, 1999
Monocyte activation in patients with Wegener's granulomatosis
A C Muller Kobold, C G Kallenberg, J W Tervaert
Kidney International
|
July 1, 1994
Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential
C G Kallenberg, E Brouwer, J J Weening, et al.
Current Opinion in Rheumatology
|
January 27, 2000
Is Wegener's granulomatosis an autoimmune disease?
P Hewins, J W Tervaert, C O Savage, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
August 8, 1987
[Analysis of symptoms preceding the diagnosis of Wegener's disease]
J W Tervaert, F J van der Woude, C G Kallenberg
Lancet (London, England)
|
January 13, 1996
c-ANCA as a marker of Wegener's disease
C F Franssen, J W Tervaert, C A Stegeman, et al.
Clinical and Experimental Immunology
|
March 1, 1993
Serum markers of T cell activation in relapses of Wegener's granulomatosis
C A Stegeman, J W Tervaert, M G Huitema, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1993
Serum markers of T-cell activation in relapses of Wegener's granulomatosis
C A Stegeman, J W Tervaert, M G Huitema, et al.
Arthritis and Rheumatism
|
April 1, 1994
Relationship between antineutrophil cytoplasmic antibody levels and disease activity in Wegener's granulomatosis: comment on the article by Kerr et al
J W Tervaert, C A Stegeman, M G Huitema, et al.
Page
of 10